Varenicline Tartrate Tablet, Film Coated
Product Images NDC 43598-907

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Varenicline Tartrate (NDC 43598-907). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddys Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Principal Display Panel (1 mg Tablet Bottle Label)

Principal Display Panel (1 mg Tablet Bottle Label)
This is a description of an unvarnished area measuring 35x35 mm with a specific reference number. Additionally, there are various alphanumeric codes and design elements in the text, indicating perhaps a design or artwork specification. The text also mentions the font used in the design, which is DRL Circular Family. This description provides details related to the dimensions and technical aspects of the design project.*
FDA Label Image

Principal Display Panel (0.5 mg Tablet Bottle Label)

Principal Display Panel (0.5 mg Tablet Bottle Label)
FDA Label Image

Principal Display Panel (1 mg Tablets Continuing Carton Pack)

Principal Display Panel (1 mg Tablets Continuing Carton Pack)
The Varenicline Tablets offer a smoking cessation aid, each tablet containing 1.71 mg varenicline tartrate equivalent to 1 mg of the active ingredient varenicline free base. Recommended dosage is one tablet in the morning and one tablet in the evening. Stored ideally at 25°C, excursions allowed between 15-30°C. This medication package contains a month's supply for continuing therapy, with 56 tablets for your next 4 weeks. Made in India and distributed by Dr. Reddy's Laboratories Inc. Be sure to refer to the Medication Guide for additional details and be mindful to dispense it to each patient.*
FDA Label Image

Principal Display Panel (1 mg Tablets Continuing Wallet Pack)

Principal Display Panel (1 mg Tablets Continuing Wallet Pack)
This text is a description found on the packaging of Varenicline Tablets, a medication used to aid in quitting smoking. It includes information on dosage, usage instructions, potential side effects, and guidance for missing a dose. The packaging also contains the manufacturer's details such as Dr. Reddy’s Laboratories Inc., the dosage content per tablet, storage instructions, and the distributor's location. Additionally, the text mentions the availability of a Medication Guide and emphasizes the importance of following the prescribed regimen for best results.*
FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
FDA Label Image

Figure 3 (Figure3)

Figure 3 (Figure3)
Not available.*
FDA Label Image
Logo (Logo)
FDA Label Image

Principal Display Panel (0.5 / 1 mg Tablet Starting Wallet Pack Back)

Principal Display Panel (0.5 / 1 mg Tablet Starting Wallet Pack Back)
FDA Label Image

Principal Display Panel (0.5 / 1 mg Tablet Starting Pack Carton)

Principal Display Panel (0.5 / 1 mg Tablet Starting Pack Carton)
FDA Label Image

Principal Display Panel (0.5 / 1 mg Tablet Starting Wallet Pack Front)

Principal Display Panel (0.5 / 1 mg Tablet Starting Wallet Pack Front)
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.